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Objectives: To determine the natural history of cartilage damage and of osteoarthritis (OA) progression
using magnetic resonance imaging (MRI); to evaluate whether OA progression varies by stage of disease.
Methods: A population-based cohortwith knee painwas assessed clinically, with X-ray (KellgreneLawrence
[KL] grading) andMRI. Cartilagewas graded 0e3 on six joint surfaces. Frequency of cartilage damage change
was determined for each joint site. Progression of OAwas deﬁned as aworsening ofMRI cartilage damage by
1 grade in at least two joint sites or2 grades in at least one joint site. The association of KL gradewith OA
progression was evaluated using parametric lifetime regression analysis.
Results: 163 subjects were assessed at baseline and follow-up (mean 3.2 years). KL grade 2 was present
in 39.4% at baseline. An increase in cartilage damage by 1 grade was seen in 8.0e14.1% of subjects at
different joint sites. OA progression on MRI was present in 15.5%. Baseline KL grade was a signiﬁcant
predictor of OA progression with hazard ratio (HR) of 6.5 (95% conﬁdence interval [CI] 1.4e30.7), 6.1 (95%
CI 1.3e28.9), and 9.2 (95% CI 1.9e44.9) for KL grades 1, 2 and 3, respectively.
Conclusion: A low OA progression rate was seen over 3 years in this population-based symptomatic
cohort. Radiographic severity, including KL grade 1, was a signiﬁcant predictor of OA progression. Future
interventions aimed at reducing progression will need to target not only radiographic OA, but also those
with early abnormalities suggestive of pre-radiographic OA.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Osteoarthritis (OA) is themost common joint diseaseworldwide
with symptomatic radiographic knee OA occurring in 6% of the
population older than 30 years1. The progression of knee OA has
been investigated extensively over several decades using radiog-
raphy. More recently, magnetic resonance imaging (MRI) has been
applied to the evaluation of structural knee abnormalities.
Although cartilage degeneration is a key feature of OA, our under-
standing of the natural history of cartilage damage, particularly atto: Jolanda Cibere, Arthritis
ncouver, BC V5Z 1L7, Canada.
ere).
s Research Society International. Pearlier stages of disease, is incomplete. Progression rates previously
reported have been variable2e6, likely related to the fact that stage
of disease, the deﬁnition of progression and the population studied
contribute to such differences. Recent research suggests that OA
progression is greater at more advanced/radiographic stages of
disease7e10. The notion that early OA might be more amenable to
disease-modiﬁcation has been entertained, but little information is
available in population-based studies on the risk of progression in
clinically evident OAwhere radiographs are normal or questionably
abnormal, i.e., pre-radiographic disease.
In this cohort we have previously reported that the majority of
subjects have pre-radiographic knee OA11,12. As such, we had the
opportunity to elucidate the question of whether risk of progres-
sion is related to stage of disease.ublished by Elsevier Ltd. All rights reserved.
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cartilage damage over 3 years in a symptomatic population-based
cohort with the full range of knee OA severity. Furthermore, we
were interested in evaluating the OA progression rate based onMRI
deﬁnition of cartilage damage changes and whether stage of
disease is a predictor of OA progression in this symptomatic cohort.
Subjects and methods
Study population
The population for this cohort study was recruited between
2002 and 2005 and has been described previously11,12. Brieﬂy,
subjects, 40e79 years old, with knee pain were recruited as
a random population sample in the Greater Vancouver area in
Canada. Recruitment was conducted using stratiﬁed sampling to
achieve equal representation within age decades and gender.
Subjects were excluded at baseline if they had inﬂammatory
arthritis or ﬁbromyalgia, previous knee arthroplasty, knee injury or
surgery within the previous 6months, knee pain referred from hips
or back, or were unable to undergo MRI. We have previously
reported that this cohort of 255 subjects seen at baseline consists of
the full spectrum of OA disease severity with 13% having no
OA (normal MRI and X-ray), 49% having pre-radiographic OA
(abnormal MRI, normal X-ray) and 38% having radiographic OA
(abnormal MRI and X-ray)12.
All subjects were invited for follow-up. Exclusion criteria at
follow-up were: (1) total knee arthroplasty; (2) inﬂammatory
arthritis; (3) inability to undergo MRI; (4) comorbidity; (5) inability
to attend the study centre. Of 255 subjects seen at baseline, 1 (0.4%)
was deceased, 25 (9.8%) were lost to follow-up with unknown
status and 35 (13.7%) were not interested in participating (Fig. 1).
The remaining 194 subjects (76.1%) were screened for eligibility. Of
these, 28 (14.4%) were not eligible and three subjects did not
complete their MRI (Fig. 1). A total of 163 subjects completed all
study assessments and were included in this analysis. All subjects
provided written informed consent. The study was conducted in
accordance with the Declaration of Helsinki and was approved by
the Clinical Research Ethics Board, University of British Columbia.255 subjects invited 
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Fig. 1. Flow diagram of study enrClinical evaluation
Subjects were evaluated comprehensively at baseline and
follow-up with questionnaires to assess demographics, knee
symptoms, OA risk factors and general health, as well as a painful
joint count based on self-report of pain in other joints over the
previous 12 months11,12. A standardized knee examination, previ-
ously shown to be reliable, was performed13. Subjects completed
the Western Ontario and McMaster Universities (WOMAC) OA
Index VA3.114. Pain, stiffness and function scores were normalized
to a 0e100 scale.
Radiographic evaluation
Baseline and follow-up knee X-rays were obtained using a ﬁxed-
ﬂexion technique with the SynaFlexer positioning frame15 and
a skyline view in the supine position. The SynaFlexer positioning
frame ﬁxes the knee ﬂexion angle for an individual subject such
that the knee positioning is identical at baseline and follow-up
examinations in longitudinal studies. Radiographs were obtained
within a month of the clinical assessment11. X-rays were scored
blinded to clinical and MRI information by two independent
readers using the KellgreneLawrence (KL) 0e4 grading16. The
interrater reliability was good, with an intraclass correlation coef-
ﬁcient of 0.7911. Differences in readings were adjudicated by
consensus readings of the two readers. Isolated patellofemoral OA
on radiographs, deﬁned as the presence of patellofemoral osteo-
phytes in conjunction with patellofemoral joint space narrowing,
was present in two of 163 subjects (1.2%).
MRI evaluation
Baseline and follow-up MRI were obtained for all subjects on
a GE 1.5T magnet using a transmit-receive extremity knee coil. The
imaging protocol included four MRI sequences, previously
described11,12: (1) Fat saturated T1-weighted three-dimensional
(3D) spoiled gradient echo (SPGR) sequence with images obtained
in the sagittal plane with reformatted images in the axial and
coronal planes; (2) Fat saturated T2-weighted fast spin echo (FSE)ions:
nee replacement: 8 (3.1%)
matory arthritis: 3 (1.2%)
 to undergo MRI: 3 (1.2%)
bidity: 9 (3.5%)
 to visit study centre: 5 (2.0%)
xcluded: 28 (14.4%)
t completed: 3
sed: 1 (0.4%)
 follow-up: 25 (9.8%)
erested: 35 (13.7%)
ollment for 3-year follow-up.
Table I
Characteristics of study population at baseline
n¼ 163
Age (years) 57.6 (10.1)
Gender (% female) 54.0%
BMI (kg/m2) 26.1 (4.2)
Pain duration (years) 11.8 (12.8)
WOMAC Pain (0e100) 19.6 (16.8)
WOMAC Stiffness (0e100) 23.7 (22.0)
WOMAC Function (0e100) 17.4 (17.0)
KL grade 0 39.9%
KL grade 1 20.7%
KL grade 2 21.2%
KL grade 3 10.0%
KL grade 4 8.2%
KL grade 2 39.4%
Data are shown as means SD, except for categorical variables where
frequencies are shown.
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(3) T1-weighted FSE sequence with images obtained in the oblique
sagittal plane (angulated according to the course of the anterior
cruciate ligament); and (4) T2-weighted FSE sequence with images
obtained in the oblique sagittal plane (angulated according to the
course of the anterior cruciate ligament).
Cartilage damage assessment
Six joint areas were assessed, including medial and lateral
tibial plateaus, medial and lateral weight bearing femoral
condyles, patella and trochlear groove. The trochlear groove was
delineated from the weight bearing surfaces of the femur by
oblique lines, tangent to the anterior tips of the anterior horns of
the medial and lateral menisci. Articular surfaces anterior to these
two lines form the trochlear groove. Cartilage was graded on
a 0e4 semi-quantitative scale based on the following deﬁnitions,
previously described by Disler et al17: 0¼ normal; 1¼ abnormal
signal without cartilage contour defect; 2¼ contour defect of
< 50% cartilage thickness; 3¼ contour defect of 50e99% cartilage
thickness; 4¼100% cartilage contour defect with subjacent bone
signal abnormality. In this study, we adapted this cartilage grading
to include not only assessment of focal defects, but also more
wide-spread damage. If multiple defects were present within
a given joint site, the most severe score was assigned. On this
scale, grade 1 does not represent a structural cartilage abnor-
mality and this score was assigned infrequently. We therefore
collapsed the original scale to a 0e3 scale, where the original
scores of 0 and 1 were collapsed to zero, and the original scores of
2, 3 and 4 were relabeled 1, 2 and 3, respectively. Baseline and
follow-up MR images were read side-by-side, blinded to time
sequence, by a single reader (AG) who was also blinded to X-ray
and clinical information. Intra-rater reliability of cartilage read-
ings have previously been reported to range from 0.84 to 1.0 for
different cartilage surfaces11. Cartilage damage worsening was
deﬁned as an increase in the damage score and cartilage damage
improvement was deﬁned as a decrease in the damage score. This
deﬁnition of cartilage worsening included incident damage in
areas of previously normal cartilage at baseline. It should also be
noted that this deﬁnition of cartilage worsening only took into
account change in lesion depth, not lesion area extent. As a result,
within-grade cartilage change was not included in our deﬁnition
of cartilage worsening. Since worsening can only occur in those
with grade 0e2 damage, subjects with cartilage grade 3 damage at
a given joint site were excluded from analysis for that site. As such,
the analysis for lateral femur, lateral tibia, medial femur, medial
tibia, patella and trochlear groove was based on exclusion of 10, 11,
13, 15, 11 and nine subjects, respectively. We also evaluated the
change in cartilage damage score using the maximum knee
cartilage score, deﬁned as the worst cartilage score at any of the
six joint sites.
Deﬁnition of OA progression
Because cartilage damage change onMRI is not equivalent to OA
progression, and because no deﬁnition of OA progression based on
MRI exists, we developed a novel deﬁnition of OA progression,
based on consensus of study investigators. Progression of OA was
deﬁned as cartilage loss of 2 grades in at least one joint site or
cartilage loss of 1 grade in at least two joint sites. This deﬁnition
was chosen to serve as a conservative deﬁnition of OA progression
based on worsening of cartilage damage at multiple sites or
worsening by a substantial amount at a single site. In addition, such
a deﬁnition allows for progression of subjects who have grade 3
damage at select joint sites.Statistical analysis
Data were summarized using frequencies, means [þstandard
deviation (SD)] or medians (þinterquartile range) as appropriate to
their distributions. In this study, exact event times were not
observed; observations were either left-censored (progression by
follow-up visit) or right-censored (no progression by follow-up
visit). To account for this type of censoring, we used exponential
regression models, which take into account differential follow-up
time, adjusted for age, gender and baseline body mass index (BMI),
to determine the hazard ratios (HR) and 95% conﬁdence intervals (CI)
for the association of radiographic stage of disease with MRI
progression rate of OA. The exponential regression likelihood func-
tion is a product of densities f(t) at observed event times, survival
functions S(t) at right-censored times, and 1S(t) at left-censored
times. Regression parameters (and therefore HRs) can be estimated
via maximum likelihood from any combination of such data18.
To obtain population-based estimates, analyses were performed
using age decade-gender stratum sampling weights. These weights
were derived as the marginal (population) probability of each age
decade-gender cell (obtained from the distribution observed
during establishment of the baseline cohort11,12) divided by sample
(actual) probability of the cell observed in this study.
All analyses were performed using SAS v9.2.
Results
One hundred and sixty-three subjects were assessed at
amedian follow-up time of 3.2 years (range 2.5e5.1). Of the original
cohort of 255 subjects, participants seen in follow-up (n¼ 163),
compared to non-participants (n¼ 92), were older (60 vs 57 years),
were more frequently male (53% vs 43%) and Caucasian (80% vs
68%), with slightly lower BMI (26.1 vs 27.2). Baseline radiographic
OA was present with similar frequency in participants and non-
participants (42% vs 39%).
Characteristics of the study population (n¼ 163) are shown in
Table I. Mean age at baseline was 57.6 years, 54.0% were female,
mean BMI of 26.1, mean duration of pain of 11.8 years and mean
normalizedWOMAC pain, stiffness and function scores of 19.6, 23.7
and 17.4, respectively. KL X-ray grade 0was seen in 39.9%, grade 1 in
20.7%, grade 2 in 21.2%, grade 3 in 10.0% and grade 4 in 8.2% of
subjects at baseline. KL grade 2 was present in 39.4%.
The change in cartilage damage scores for each joint site and for
the maximum knee cartilage score from baseline to 3-year follow-
up are shown in Table II. In the lateral tibiofemoral (TF) compart-
ment, only 8.1% and 6.4% of subjects had an increase in cartilage
damage score in the femoral and tibial cartilage, respectively. In the
Table II
Change in MRI cartilage damage score by 1 grade (0e3 scale) from baseline to
follow-up
Increased (%) Unchanged (%) Decreased (%)
Lateral femoral cartilage score 8.1 89.8 2.1
Lateral tibial cartilage score 6.4 93.6 0
Medial femoral cartilage score 14.1 84.2 1.7
Medial tibial cartilage score 8.9 90.6 0.5
Patellar cartilage score 8.0 92.0 0
Trochlear groove cartilage score 8.6 90.6 0.8
Maximum knee cartilage score* 22.7 76.6 0.7
* Maximum knee cartilage score was deﬁned as theworst cartilage grade at any of
the six joint sites (see methodology)
Table III
Association of radiographic stage of disease with OA progression on MRI*
Unadjusted HR (95% CI) Adjusted HRy (95% CI)
KL grade 0 Referent Referent
KL grade 1 7.0 (1.5e32.8) 6.5 (1.4e30.6)
KL grade 2 6.9 (1.5e31.9) 6.1 (1.3e28.9)
KL grade 3 11.6 (2.6e52.2) 9.2 (1.9e44.8)
* OA progression on MRI was deﬁned as cartilage loss of 2 grades in at least one
joint site or cartilage loss of 1 grade in at least two joint sites (see methodology)
y Analyses adjusted for age, gender and BMI. Statistically signiﬁcant results are in
bold print.
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seen in 14.1% and 8.9% for the femoral and tibial cartilage, respec-
tively. In the patellar and trochlear groove cartilage, increased
scores were seen in 8.0 and 8.6%, respectively. Using the maximum
cartilage score at any joint site of the knee, an increase in cartilage
damage was seen in 22.7% of subjects. A decrease in cartilage
damage score was seen infrequently, ranging from 0% to 2.1% at
different joint sites.
Overall, OA progression on MRI was seen in 15.5% of subjects
(Fig. 2). For KL grades 0, 1, 2, 3 and 4, OA progression rates were
3.2%, 20.7%, 21.2%, 36.2% and 22.4%, respectively (Fig. 2). For
subjects with KL grade 2, OA progression was 25.2% compared
to a progression rate of 9.2% in those with KL grade <2. KL grade
was a signiﬁcant predictor of OA MRI progression with a HR
(compared to KL grade 0) of 6.5 (95% CI 1.4e30.6) for KL grade 1,
HR of 6.1 (95% CI 1.3-28.9) for KL grade 2, and HR of 9.2 (95% CI
1.9e44.8) for KL grade 3, after adjustment for age, gender and
BMI (Table III).
Discussion
In this study, we report that worsening of cartilage, including
incident damage in previously normal cartilage, occurred in 22.7%
of subjects in this symptomatic population-based cohort with
predominantly pre-radiographic stage of knee OA. Furthermore, we
developed a deﬁnition of OA progression based on MRI and report
an OA progression rate of 15.5%. Radiographic stage of disease,
including KL grade 1, was signiﬁcantly associated with an increased
risk of OA progression.15.5%
3.2%
20.7% 21.2%
36.2%
22.4%
0%
10%
20%
30%
40%
50%
Overall 0 1 2 3 4
Baseline Kellgren-Lawrence x-ray grade
P
r
o
g
r
e
s
s
io
n
 r
a
t
e
Fig. 2. Knee OA progression rate from baseline to 3-year follow-up e overall and by
KL grade severity. OA progression on MRI was deﬁned as cartilage loss of 2 grades in
at least one joint site or cartilage loss of 1 grade in at least two joint sites
(see methodology).In longitudinal MRI studies, progression rates of cartilage
defects/damage based on semi-quantitative scoring have been
reported to range from 17% to 68% over 1.8 to 2.5 years2e6. Higher
rates of cartilage progression were seen in studies that included
predominantly or exclusively subjects with radiographic OA2e4.
Amin et al2 reported progression of cartilage damage by 1 score
(0e4 scale, based on modiﬁed Whole Organ MRI Score19) in 46%
and 22% of knees in the medial and lateral compartments, respec-
tively, over 2.5 years in symptomatic subjects, of whom 72% had
a KL grade 2. Davies-Tuck et al3 reported worsening of cartilage
defects of 32e68% at different joint sites in a convenience sample of
subjects with radiographic OA over 2 years. In a retrospective study
by Biswal et al4, in subjects with predominantly sports or motor
vehicle accident injuries, development of new lesions and
progression of lesions occurred frequently over 1.8 years. In that
study, cartilage damage was assessed by grading lesion depth as
well as size, which might account for the high rate of progression
over a short period of time4.
In contrast, studies that have included earlier disease
cohorts have reported lower cartilage progression rates5,6.
Boegard et al5 included subjects aged 41e57 with chronic knee
pain, only 32% of which had evidence of radiographic knee OA.
An increase in cartilage defects was seen in 34% of lesions over
2 years5. In a study by Ding et al6, where evidence of radio-
graphic OA was present in 17% of subjects, worsening of MRI
cartilage defects in any compartment by 1 score (0e4 scale)
was reported in 33% of subjects at 2.3 years. Similar to the latter
two studies, our cohort consisted predominantly of pre-radio-
graphic OA and, in keeping with these studies, we have
demonstrated a relatively low cartilage damage progression
rate of 22.7% over 3 years.
Regression of cartilage damage occurred infrequently in our
study. Other studies, with one exception5 have reported higher
frequencies of regression of cartilage damage3,6,20. It is not clear
whether such differences in regression rates relate to stage of
disease, methodology of MRI evaluations, such as MRI readings that
are blinded to time sequence vs unblinded, or whether there is true
regression.
In addition to reporting worsening of cartilage damage, wewere
interested in evaluating OA progression rates, using a deﬁnition
based on MRI cartilage change. Although MRI has been used
extensively to assess cartilage loss, it is unclear which of the many
cartilage outcome measures are most responsive or most valid21
and, to date, no standard MRI deﬁnition of OA progression exists.
Our deﬁnition of OA progression has the advantage of using carti-
lage information from the knee as a whole and therefore reports
a single progression rate, rather than progression of individual joint
sites or compartments. More importantly, it serves as a conserva-
tive estimate of cartilage worsening, since a 1-grade change has to
occur in at least two joint sites or a 2-grade change in at least one
joint site, thereby minimizing the assignment of progression in
cases where cartilage change is due to reader error. With this
deﬁnition, we found an OA progression rate of 15.5% in this
J. Cibere et al. / Osteoarthritis and Cartilage 19 (2011) 683e688 687symptomatic cohort. Amin et al2 reported medial TF cartilage
progression of 2 grades in at least one region in 14% of subjects
and any cartilage loss at 2 regions in 21% of subjects, with lower
frequencies seen in the lateral TF compartment. These rates are in
keeping with our results. We are not aware of any other MRI studies
reporting a similar outcome measure.
In this study, we report an increased risk of OA progression in
subjects with radiographic abnormalities at baseline compared to
those with normal X-rays. Interestingly, we also found that the risk
of OA progression was similar in those with KL grade 1 [odds ratio
(OR) 6.5] and KL grade 2 (OR 6.1), suggesting that KL grade 1 is
a true disease entity, supporting the notion of ‘pre-radiographic’
disease. Our results are in keeping with previous studies where
radiographic structural abnormalities, including KL grade 1, were
reported to predict OA radiographic progression22e24. Similarly, in
recent MRI studies, advanced stage of disease, assessed by radio-
graphic joint space narrowing7,8 or by cartilage defect severity9,10,
was associated with cartilage volume loss, both in healthy adults
and in radiographic OA. Only one study reported that the presence
of cartilage defects was not associated with cartilage volume loss
over 2 years in the medial and lateral TF compartments, although
an association was found for the patellofemoral compartment25.
Our study is limited by the fact that we did not include an
asymptomatic control group. As such, our ﬁndings are only
generalizable to symptomatic populations. The development of
a deﬁnition of OA progression based on MRI provides useful
information, although this deﬁnition requires further validation in
relation to symptomatic and structural outcomes. Our deﬁnition of
cartilage worsening only took into account change in lesion depth,
not lesion area extent. As a result, our study may have under-
estimated the rate of cartilage worsening. The choice of MRI
sequence may also inﬂuence ﬁndings for progression or regression.
In this study, assessment of cartilage damage was performed using
the three sequences available, i.e., 3D sagittal SPGR with coronal
and axial reformatted images, sagittal oblique dual-echo FSE
T2-weighted and coronal fat-suppressed T2-weighted MRI. It is
known that 3D gradient echo-type sequences are not ideal for focal
defects26,27. Hence misclassiﬁcation, speciﬁcally underscoring of
focal cartilage defects, might occur with this type of sequence.
While 3D gradient echo-type sequences may be suggestive of
remaining cartilage, dual-echo and T2-weighted spin echo
sequences may show full thickness loss. For this reason overscoring
of cartilage damage on gradient echo sequences is also possible.
When doubt persisted regarding cartilage grading, the lower
cartilage grade was assigned. Cartilage assessment may also be
inﬂuenced by MRI artifacts, leading to false-positive and false-
negative ﬁndings. These include motion artifacts with the use of
any MRI sequence, susceptibility artifacts that are especially rele-
vant in 3D gradient echo-type sequences and partial volume effects
which are seen in two-dimensional (2D) sequences with relatively
thick slices.
The strengths of this study include the evaluation of a pop-
ulation-based cohort which allows for generalizability of results to
the symptomatic population at large. This cohort includes the full
spectrum of knee OA severity, which enhances our understanding
of cartilage loss and OA progression at early pre-radiographic stage
of disease.
In conclusion, in this population-based cohort with knee pain,
OA progression over 3 years, deﬁned by MRI, occurred in 15.5%
of subjects. Radiographic stage of disease, including KL grade 1,
was predictive of OA progression. Future interventions aimed at
reducing progression of OA will therefore need to target not only
symptomatic subjects with radiographic stages of disease, but
also those with early abnormalities suggestive of pre-radio-
graphic OA.Contributions
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